Clinical Trial Update: Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study [Phase 3]

View source ↗

Summary

Phase 3 study updating long-term safety and efficacy of inhaled dry powder mannitol in cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Mannitol (inhaled dry powder) (Mannitol)

Snippet

Sponsor: Syntara | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED